Moderna : AACR INT Head & Neck Poster -April 08, 2024 at 04:52 pm EDT
CT141 mRNA-4157 Individualized Neoantigen Therapy +...
Stay updated with breaking news from Step Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CT141 mRNA-4157 Individualized Neoantigen Therapy +...
Step Pharma says pre-clinical data on its first-in-class, highly selective, orally bioavailable CTPS1 inhibitor, STP938 is encouraging.
Investegate announcements from Step Pharma, Step Pharma to Present Promising Data on the Therapeutic Potential of Selective Small Molecule Inhibition of CTPS1 at the 64th American Society of Hematology Annual Meeting
Robert A. Copeland, PhD and Adrian M. Senderowicz, MD join Scientific Advisory BoardWALTHAM, MA / ACCESSWIRE / June 23, 2022 / TRIANA Biomedicines, Inc. (TRIANA), a leading biopharmaceutical company focused
Press release content from Accesswire. The AP news staff was not involved in its creation.